The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus

Cancer Letters

Volumn 177, Issue 1, 2002, Pages 101-105

  Nakakubo, Yoshihiro ^a   Hida, Yasuhiro ^a   Miyamoto, Masaki ^a   Hashida, Hideaki ^a   Oshikiri, Taro ^a   Kato, Kentaro ^a   Suzuoki, Masato ^a   Hiraoka, Kei ^a   Ito, Tomoo ^b   Morikawa, Toshiaki ^a   Okushiba, Shunichi ^a   Kondo, Satoshi ^a   Katoh, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Surgical Pathology ^*  (Japan)

Author keywords

Immunohistochemistry; Oesophagus; Prognostic factor; RCAS1; Squamous cell carcinoma

Indexed keywords

PROTEIN RCAS1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 18244388246     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00773-X     Document Type: Article

References (16)

1. Improvement in the results of surgical treatment of advanced squamous oesophageal carcinoma during 15 consecutive years
2. Pathologic prognosis factors in Barrett's associated adenocarcinoma: A follow-up study of 96 patients
3. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus
4. A. novel tumour-associated antigen expressed in human uterine and ovarian carcinomas
5. Tumour-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias
6. Expression and prognostic significance in lung cancer of human tumour-associated antigen RCAS1
7. Inhibition of cell growth and induction of apoptotic cell death by the human tumour- associated antigen RCAS1
8. The role of natural killer cells in immune surveillance of cancer
9. Promotor analysis and chromosomal mapping of human EBAG9 gene
10. The prognostic significance of tumour-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix
11. Expression of a tumour-associated antigen RCAS1 in hepatocellular carcinoma
12. Molecular cytogenetic analysis of 17 renal cancer cell lines: Increased copy number at 5q31-33 in cell lines from non-papillary carcinoma
13. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence
14. Gains of 8q23-qter and 20p and loss of 11q22-qter in oesophageal squamous cell carcinoma associated with lymph node metastasis
15. The anti-human tumour effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the interleukin-6 gene using adenovirus vector